For hemodialysis patients and nephrologists dealing with catheter-related infections and for catheter selling companies seeking antimicrobial and innovative solutions, the GOcap® is the first graphene light-activated catheter cap that continuously prevents infection in dialysis patients.
Unlike other caps in the market, GOcap® is reusable, self-sterilizable and provides long-term antimicrobial action inside the catheter hub, at a low cost, while avoiding antibiotics’ use.
For hemodialysis patients and nephrologists dealing with catheter-related infections and for catheter selling companies seeking antimicrobial and innovative solutions, the GOcap® is the first graphene light-activated catheter cap that continuously prevents infection in dialysis patients.
Unlike other caps in the market, GOcap® is reusable, self-sterilizable and provides long-term antimicrobial action inside the catheter hub, at a low cost, while avoiding antibiotics’ use.
It is a versatile cap that can be used in different catheters and other infection-prone medical devices, and can be safely applied at home or at healthcare facilities.
It is comprised by 5 main components.
A plastic cap, holding a battery that powers a NIR emitting light source, which is connected to a waveguide coated with graphene oxide (GO).
When the light source is on, light travels through the waveguide, irradiating GO and triggering its antimicrobial action, killing bacteria in the hub by photothermal and photodynamic action, hampering biofilm formation and infection.
Kills 99% of clinically-relevant bacteria inside the catheter hub, preventing catheter-related infection.
Low price and cheaper than standard caps over time.
Can be used multiple times for the same patient.
Antimicrobial action relies on graphene, so no need for antibiotics.
Kills 99% of clinically-relevant bacteria inside the catheter hub, preventing catheter-infection.
Low price and cheaper than standard caps over time.
Can be used multiple times for the same patient.
Antimicrobial action relies on graphene, so no need for antibiotics.
Our patented technology relies on the irradiation of graphene with safe, low power, near-infrared light that kills 99% of the bacteria commonly found in infected catheters, including antibiotics resistant ones.
This technology can be applied for the disinfection of other catheters, medical devices, or any liquid where bacteria can grow.
GOTECH Antimicrobial holds exclusive commercial exploitation rights of this patent.
Our patented technology relies on the irradiation of graphene with safe, low power, near-infrared light that kills 99% of the bacteria commonly found in infected catheters, including antibiotics resistant ones.
This technology can be applied for the disinfection of other catheters, medical devices, or any liquid where bacteria can grow.
GOTECH Antimicrobial holds exclusive commercial exploitation rights of this patent.
A clinical study is expected to be performed in 2024/2025, where GOcap® will be benchmarked against standard caps in a randomized clinical trial with haemodialysis patients.
If you are interested in participating in a clinical study, please contact us.
A clinical study is expected to be performed in 2024/2025, where GOcap® will be benchmarked against standard caps in a randomized clinical trial with haemodialysis patients.
If you are interested in participating in a clinical study, please contact us.
hello@gotechantimicrobial.com
© 2024 All Rights Reserved.
